SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-009139
Filing Date
2020-05-15
Accepted
2020-05-15 16:32:00
Documents
86
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 803271
2 ex31-1.htm EX-31.1 11338
3 ex31-2.htm EX-31.2 11374
4 ex32-1.htm EX-32.1 7727
5 ex32-2.htm EX-32.2 7669
  Complete submission text file 0001493152-20-009139.txt   4730679

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cdxi-20200331.xml EX-101.INS 721066
7 XBRL SCHEMA FILE cdxi-20200331.xsd EX-101.SCH 69818
8 XBRL CALCULATION FILE cdxi-20200331_cal.xml EX-101.CAL 73908
9 XBRL DEFINITION FILE cdxi-20200331_def.xml EX-101.DEF 234903
10 XBRL LABEL FILE cdxi-20200331_lab.xml EX-101.LAB 423615
11 XBRL PRESENTATION FILE cdxi-20200331_pre.xml EX-101.PRE 348942
Mailing Address 2800 WOODLAWN DRIVE SUITE 129 HONOLULU HI 96822
Business Address 2800 WOODLAWN DRIVE SUITE 129 HONOLULU HI 96822 808-457-1400
CARDAX, INC. (Filer) CIK: 0001544238 (see all company filings)

IRS No.: 454484428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-181719 | Film No.: 20885938
SIC: 2834 Pharmaceutical Preparations